CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease
复制标题
DOI:
10.1212/01.wnl.0000230159.67128.00
复制
发表时间:
2006-08-22
期刊:
影响因子:
9.9
通讯作者:
Zerr, I.
中科院分区:
文献类型:
--
作者:
Sanchez-Juan, P.;Green, A.;Zerr, I.
Objectives: To analyze the diagnostic sensitivity and specificity of various brain-derived proteins (14-3-3, Tau, neuron specific enolase [NSE], and S100b) in the CSF of patients with Creutzfeldt-Jakob disease (CJD) and to analyze biologic factors that modify these parameters. Methods: CSF was tested for 14-3-3, Tau, NSE, and S100b in 1,859 patients with sporadic, genetic, iatrogenic, and variant CJD, and in 1,117 controls. Results: The highest sensitivity was achieved for 14-3-3 and Tau in sporadic CJD (85% and 86%), and a combined determination of 14-3-3 and Tau, S100b, or NSE increased the sensitivity to over 93%. A multivariate analysis showed that the sensitivity of all tests was highest in patients with the shortest disease duration, age at onset > 40 years, and homozygosity at codon 129 of the prion protein gene. In a group of patients with repeated lumbar punctures, a second test also increased the diagnostic sensitivity. Conclusions: The detection of elevated levels of brain-derived proteins in the CSF in patients with suspected CreutzfeldtJakob disease is a valuable diagnostic test. A second lumbar puncture may be of value in patients with atypical clinical course in whom the first test was negative.